Spots Global Cancer Trial Database for grade 4 malignant glioma
Every month we try and update this database with for grade 4 malignant glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Bevacizumab Beyond Progression (BBP) | NCT01740258 | Malignant Gliom... Grade 4 Maligna... Glioblastoma Gliosarcoma | Radiation Thera... Temozolomide Bevacizumab | 18 Years - | Duke University | |
Bevacizumab Beyond Progression (BBP) | NCT01740258 | Malignant Gliom... Grade 4 Maligna... Glioblastoma Gliosarcoma | Radiation Thera... Temozolomide Bevacizumab | 18 Years - | Duke University |